MERCIALYS (MERY.PA)

FR0010241638 - REIT

10.03  +0.09 (+0.91%)

Fundamental Rating

6

Overall MERY gets a fundamental rating of 6 out of 10. We evaluated MERY against 45 industry peers in the Diversified REITs industry. While MERY has a great profitability rating, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on MERY. These ratings could make MERY a good candidate for value investing.



7

1. Profitability

1.1 Basic Checks

In the past year MERY was profitable.
In the past year MERY had a positive cash flow from operations.
MERY had positive earnings in each of the past 5 years.
Each year in the past 5 years MERY had a positive operating cash flow.

1.2 Ratios

The Return On Assets of MERY (4.25%) is better than 85.71% of its industry peers.
The Return On Equity of MERY (14.37%) is better than 100.00% of its industry peers.
MERY has a better Return On Invested Capital (5.34%) than 90.48% of its industry peers.
MERY had an Average Return On Invested Capital over the past 3 years of 4.23%. This is in line with the industry average of 3.47%.
The 3 year average ROIC (4.23%) for MERY is below the current ROIC(5.34%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.25%
ROE 14.37%
ROIC 5.34%
ROA(3y)2.31%
ROA(5y)2.75%
ROE(3y)7.4%
ROE(5y)9.66%
ROIC(3y)4.23%
ROIC(5y)4.6%

1.3 Margins

MERY has a Profit Margin of 33.25%. This is in the better half of the industry: MERY outperforms 71.43% of its industry peers.
MERY's Profit Margin has declined in the last couple of years.
MERY's Operating Margin of 53.75% is on the low side compared to the rest of the industry. MERY is outperformed by 71.43% of its industry peers.
MERY's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 95.83%, MERY belongs to the top of the industry, outperforming 88.10% of the companies in the same industry.
MERY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 53.75%
PM (TTM) 33.25%
GM 95.83%
OM growth 3Y-15.98%
OM growth 5Y-10.78%
PM growth 3Y-15.06%
PM growth 5Y-7.03%
GM growth 3Y4.56%
GM growth 5Y0.5%

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MERY is still creating some value.
The number of shares outstanding for MERY remains at a similar level compared to 1 year ago.
MERY has more shares outstanding than it did 5 years ago.
The debt/assets ratio for MERY has been reduced compared to a year ago.

2.2 Solvency

MERY has an Altman-Z score of 0.88. This is a bad value and indicates that MERY is not financially healthy and even has some risk of bankruptcy.
MERY has a Altman-Z score (0.88) which is comparable to the rest of the industry.
MERY has a debt to FCF ratio of 7.67. This is a slightly negative value and a sign of low solvency as MERY would need 7.67 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 7.67, MERY belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
MERY has a Debt/Equity ratio of 1.85. This is a high value indicating a heavy dependency on external financing.
MERY has a Debt to Equity ratio of 1.85. This is amonst the worse of the industry: MERY underperforms 97.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.85
Debt/FCF 7.67
Altman-Z 0.88
ROIC/WACC1.11
WACC4.81%

2.3 Liquidity

A Current Ratio of 2.38 indicates that MERY has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.38, MERY belongs to the top of the industry, outperforming 97.62% of the companies in the same industry.
MERY has a Quick Ratio of 2.38. This indicates that MERY is financially healthy and has no problem in meeting its short term obligations.
MERY has a Quick ratio of 2.38. This is amongst the best in the industry. MERY outperforms 97.62% of its industry peers.
Industry RankSector Rank
Current Ratio 2.38
Quick Ratio 2.38

5

3. Growth

3.1 Past

MERY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.12%, which is quite impressive.
Measured over the past years, MERY shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.32% on average per year.
Looking at the last year, MERY shows a very strong growth in Revenue. The Revenue has grown by 54.05%.
The Revenue has been decreasing by -1.01% on average over the past years.
EPS 1Y (TTM)45.12%
EPS 3Y-15.36%
EPS 5Y-8.32%
EPS Q2Q%17.51%
Revenue 1Y (TTM)54.05%
Revenue growth 3Y0.49%
Revenue growth 5Y-1.01%
Sales Q2Q%3.85%

3.2 Future

MERY is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.47% yearly.
The Revenue is expected to grow by 2.27% on average over the next years.
EPS Next Y5.5%
EPS Next 2Y5.91%
EPS Next 3Y5.47%
EPS Next 5YN/A
Revenue Next Year2.16%
Revenue Next 2Y2.28%
Revenue Next 3Y2.27%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.45 indicates a reasonable valuation of MERY.
Based on the Price/Earnings ratio, MERY is valued a bit cheaper than the industry average as 78.57% of the companies are valued more expensively.
MERY's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.73.
MERY is valuated reasonably with a Price/Forward Earnings ratio of 8.77.
Based on the Price/Forward Earnings ratio, MERY is valued a bit cheaper than 73.81% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.83, MERY is valued rather cheaply.
Industry RankSector Rank
PE 10.45
Fwd PE 8.77

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MERY is valued cheaper than 90.48% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MERY is valued cheaply inside the industry as 97.62% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.95
EV/EBITDA 10.82

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
MERY has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.9
PEG (5Y)N/A
EPS Next 2Y5.91%
EPS Next 3Y5.47%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.96%, MERY is a good candidate for dividend investing.
MERY's Dividend Yield is rather good when compared to the industry average which is at 7.61. MERY pays more dividend than 88.10% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, MERY pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.96%

5.2 History

The dividend of MERY decreases each year by -4.03%.
Dividend Growth(5Y)-4.03%
Div Incr Years3
Div Non Decr Years3

5.3 Sustainability

103.37% of the earnings are spent on dividend by MERY. This is not a sustainable payout ratio.
DP103.37%
EPS Next 2Y5.91%
EPS Next 3Y5.47%

MERCIALYS

EPA:MERY (12/20/2024, 7:00:00 PM)

10.03

+0.09 (+0.91%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)07-24 2024-07-24
Earnings (Next)02-12 2025-02-12/amc
Inst Owners44.24%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap941.72M
Analysts70.77
Price Target12.75 (27.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 9.96%
Dividend Growth(5Y)-4.03%
DP103.37%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.27%
PT rev (3m)0.11%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-3.08%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.05%
Valuation
Industry RankSector Rank
PE 10.45
Fwd PE 8.77
P/S 3.49
P/FCF 5.95
P/OCF 5.95
P/B 1.51
P/tB 1.52
EV/EBITDA 10.82
EPS(TTM)0.96
EY9.57%
EPS(NY)1.14
Fwd EY11.41%
FCF(TTM)1.69
FCFY16.81%
OCF(TTM)1.69
OCFY16.81%
SpS2.87
BVpS6.64
TBVpS6.61
PEG (NY)1.9
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.25%
ROE 14.37%
ROCE 7.27%
ROIC 5.34%
ROICexc 5.59%
ROICexgc 5.6%
OM 53.75%
PM (TTM) 33.25%
GM 95.83%
FCFM 58.74%
ROA(3y)2.31%
ROA(5y)2.75%
ROE(3y)7.4%
ROE(5y)9.66%
ROIC(3y)4.23%
ROIC(5y)4.6%
ROICexc(3y)4.68%
ROICexc(5y)5.15%
ROICexgc(3y)4.69%
ROICexgc(5y)5.16%
ROCE(3y)5.75%
ROCE(5y)6.26%
ROICexcg growth 3Y-16.87%
ROICexcg growth 5Y-13.42%
ROICexc growth 3Y-16.85%
ROICexc growth 5Y-13.42%
OM growth 3Y-15.98%
OM growth 5Y-10.78%
PM growth 3Y-15.06%
PM growth 5Y-7.03%
GM growth 3Y4.56%
GM growth 5Y0.5%
F-Score7
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 1.85
Debt/FCF 7.67
Debt/EBITDA 6.07
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 3.22
Cash Conversion 83.22%
Profit Quality 176.67%
Current Ratio 2.38
Quick Ratio 2.38
Altman-Z 0.88
F-Score7
WACC4.81%
ROIC/WACC1.11
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)272.74%
Profit Quality(5y)229.38%
High Growth Momentum
Growth
EPS 1Y (TTM)45.12%
EPS 3Y-15.36%
EPS 5Y-8.32%
EPS Q2Q%17.51%
EPS Next Y5.5%
EPS Next 2Y5.91%
EPS Next 3Y5.47%
EPS Next 5YN/A
Revenue 1Y (TTM)54.05%
Revenue growth 3Y0.49%
Revenue growth 5Y-1.01%
Sales Q2Q%3.85%
Revenue Next Year2.16%
Revenue Next 2Y2.28%
Revenue Next 3Y2.27%
Revenue Next 5YN/A
EBIT growth 1Y65.27%
EBIT growth 3Y-15.57%
EBIT growth 5Y-11.68%
EBIT Next Year26.35%
EBIT Next 3Y9.85%
EBIT Next 5YN/A
FCF growth 1Y0.38%
FCF growth 3Y-0.15%
FCF growth 5Y-4.17%
OCF growth 1Y0.38%
OCF growth 3Y-0.15%
OCF growth 5Y-4.17%